ZHOU HAIRONG
No ORCID on file
· 24 papers in corpus
· active 1997-2008
Frequent coauthors
2008
The invention relates to compounds represented by formula I: which are irreversible inhibitors of tyrosine kinazes, to pharmaceutiyal compositions containing the same and to the use thereof in the treatment of cancer, atherosclerosis, reste…
2008
The invention relates to compounds represented by formula I: which are irreversible inhibitors of tyrosine kinazes, to pharmaceutiyal compositions containing the same and to the use thereof in the treatment of cancer, atherosclerosis, reste…
2008
The invention relates to compounds represented by formula I: which are irreversible inhibitors of tyrosine kinazes, to pharmaceutiyal compositions containing the same and to the use thereof in the treatment of cancer, atherosclerosis, reste…
2008
The invention relates to compounds represented by formula I: which are irreversible inhibitors of tyrosine kinazes, to pharmaceutiyal compositions containing the same and to the use thereof in the treatment of cancer, atherosclerosis, reste…
2008
The invention relates to compounds represented by formula I: which are irreversible inhibitors of tyrosine kinazes, to pharmaceutiyal compositions containing the same and to the use thereof in the treatment of cancer, atherosclerosis, reste…
2008
The invention relates to compounds represented by formula I: which are irreversible inhibitors of tyrosine kinazes, to pharmaceutiyal compositions containing the same and to the use thereof in the treatment of cancer, atherosclerosis, reste…
2003
The present invention provides compounds that are irreversible inhibitors of tyrosine kinases. Also provided is a method of treating cancer, restenosis, atherosclerosis, endometriosis, and psoriasis and a pharmaceutical composition that …
2003
The present invention provides compounds that are irreversible inhibitors of tyrosine kinases. Also provided is a method of treating cancer, restenosis, atherosclerosis, endometriosis, and psoriasis and a pharmaceutical composition that …
2003
The present invention provides compounds that are irreversible inhibitors of tyrosine kinases. Also provided is a method of treating cancer, restenosis, atherosclerosis, endometriosis, and psoriasis and a pharmaceutical composition that …
2003
The present invention provides compounds that are irreversible inhibitors of tyrosine kinases. Also provided is a method of treating cancer, restenosis, atherosclerosis, endometriosis, and psoriasis and a pharmaceutical composition that …
2003
The present invention provides compounds that are irreversible inhibitors of tyrosine kinases. Also provided is a method of treating cancer, restenosis, atherosclerosis, endometriosis, and psoriasis and a pharmaceutical composition that …
2003
The present invention provides compounds that are irreversible inhibitors of tyrosine kinases. Also provided is a method of treating cancer, restenosis, atherosclerosis, endometriosis, and psoriasis and a pharmaceutical composition that …
2002
The present invention provides compounds that are irreversible inhibitors of tyrosine kinases. Also provided is a method of treating cancer, restenosis, atherosclerosis, endometriosis, and psoriasis and a pharmaceutical composition that …
2002
The present invention provides compounds that are irreversible inhibitors of tyrosine kinases. Also provided is a method of treating cancer, restenosis, atherosclerosis, endometriosis, and psoriasis and a pharmaceutical composition that …
2002
The present invention provides compounds that are irreversible inhibitors of tyrosine kinases. Also provided is a method of treating cancer, restenosis, atherosclerosis, endometriosis, and psoriasis and a pharmaceutical composition that …
2002
The present invention provides compounds that are irreversible inhibitors of tyrosine kinases. Also provided is a method of treating cancer, restenosis, atherosclerosis, endometriosis, and psoriasis and a pharmaceutical composition that …
2002
The present invention provides compounds that are irreversible inhibitors of tyrosine kinases. Also provided is a method of treating cancer, restenosis, atherosclerosis, endometriosis, and psoriasis and a pharmaceutical composition that …
2002
The present invention provides compounds that are irreversible inhibitors of tyrosine kinases. Also provided is a method of treating cancer, restenosis, atherosclerosis, endometriosis, and psoriasis and a pharmaceutical composition that …
1997
The present invention provides compounds that are irreversible inhibitors of tyrosine kinases. Also provided is a method of treating cancer, restenosis, atherosclerosis, endometriosis, and psoriasis and a pharmaceutical composition that com…
1997
The present invention provides compounds that are irreversible inhibitors of tyrosine kinases. Also provided is a method of treating cancer, restenosis, atherosclerosis, endometriosis, and psoriasis and a pharmaceutical composition that com…
1997
The present invention provides compounds that are irreversible inhibitors of tyrosine kinases. Also provided is a method of treating cancer, restenosis, atherosclerosis, endometriosis, and psoriasis and a pharmaceutical composition that com…
1997
The present invention provides compounds that are irreversible inhibitors of tyrosine kinases. Also provided is a method of treating cancer, restenosis, atherosclerosis, endometriosis, and psoriasis and a pharmaceutical composition that com…
1997
The present invention provides compounds that are irreversible inhibitors of tyrosine kinases. Also provided is a method of treating cancer, restenosis, atherosclerosis, endometriosis, and psoriasis and a pharmaceutical composition that com…
1997
The present invention provides compounds that are irreversible inhibitors of tyrosine kinases. Also provided is a method of treating cancer, restenosis, atherosclerosis, endometriosis, and psoriasis and a pharmaceutical composition that com…